HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
Standard
HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis. / Mohme, Malte; Hotz, Christian; Stevanovic, Stefan; Binder, Thomas; Lee, Jar-How; Okoniewski, Michal; Eiermann, Thomas; Sospedra, Mireia; Rammensee, Hans-Georg; Martin, Roland.
In: BRAIN, Vol. 136, No. Pt 6, Pt 6, 2013, p. 1783-1798.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
AU - Mohme, Malte
AU - Hotz, Christian
AU - Stevanovic, Stefan
AU - Binder, Thomas
AU - Lee, Jar-How
AU - Okoniewski, Michal
AU - Eiermann, Thomas
AU - Sospedra, Mireia
AU - Rammensee, Hans-Georg
AU - Martin, Roland
PY - 2013
Y1 - 2013
N2 - The HLA-DR15 haplotype confers the largest part of the genetic risk to develop multiple sclerosis, a prototypic CD4+ T cell-mediated autoimmune disease. The mechanisms how certain HLA-class II molecules functionally contribute to autoimmune diseases are still poorly understood, but probably involve shaping an autoimmune-prone T cell repertoire during central tolerance in the thymus and subsequently maintaining or even expanding it in the peripheral immune system. Self-peptides that are presented by disease-associated HLA-class II molecules most likely play important roles during both processes. Here, we examined the functional involvement of the HLA-DR15 haplotype in autologous proliferation in multiple sclerosis and the contribution of HLA-DR15 haplotype-derived self-peptides in an in vitro system. We observe increased autologous T cell proliferation in patients with multiple sclerosis in relation to the multiple sclerosis risk-associated HLA-DR15 haplotype. Assuming that the spectrum of self-peptides that is presented by the two HLA-DR15 allelic products is important for sustaining autologous proliferation we performed peptide elution and identification experiments from the multiple sclerosis-associated DR15 molecules and a systematic analysis of a DR15 haplotype-derived self-peptide library. We identify HLA-derived self-peptides as potential mediators of altered autologous proliferation. Our data provide novel insights about perturbed T cell repertoire dynamics and the functional involvement of the major genetic risk factor, the HLA-DR15 haplotype, in multiple sclerosis.
AB - The HLA-DR15 haplotype confers the largest part of the genetic risk to develop multiple sclerosis, a prototypic CD4+ T cell-mediated autoimmune disease. The mechanisms how certain HLA-class II molecules functionally contribute to autoimmune diseases are still poorly understood, but probably involve shaping an autoimmune-prone T cell repertoire during central tolerance in the thymus and subsequently maintaining or even expanding it in the peripheral immune system. Self-peptides that are presented by disease-associated HLA-class II molecules most likely play important roles during both processes. Here, we examined the functional involvement of the HLA-DR15 haplotype in autologous proliferation in multiple sclerosis and the contribution of HLA-DR15 haplotype-derived self-peptides in an in vitro system. We observe increased autologous T cell proliferation in patients with multiple sclerosis in relation to the multiple sclerosis risk-associated HLA-DR15 haplotype. Assuming that the spectrum of self-peptides that is presented by the two HLA-DR15 allelic products is important for sustaining autologous proliferation we performed peptide elution and identification experiments from the multiple sclerosis-associated DR15 molecules and a systematic analysis of a DR15 haplotype-derived self-peptide library. We identify HLA-derived self-peptides as potential mediators of altered autologous proliferation. Our data provide novel insights about perturbed T cell repertoire dynamics and the functional involvement of the major genetic risk factor, the HLA-DR15 haplotype, in multiple sclerosis.
M3 - SCORING: Journal article
VL - 136
SP - 1783
EP - 1798
JO - BRAIN
JF - BRAIN
SN - 0006-8950
IS - Pt 6
M1 - Pt 6
ER -